Theon International (THEON) Q3 2025 TU earnings summary

Executive summary

• Revenue for the nine months ended 30 September 2025 rose 25.5% year-over-year to €279.3 million, driven by new contract awards and options exercised under existing contracts.

• Adjusted EBIT increased 32.8% to €69.4 million, with an improved margin of 24.8% versus 23.5% last year.

• Net profit attributable to shareholders reached €49.1 million, up from €38.6 million in the prior year period.

• Earnings per share increased by 25.0% year-over-year to €0.70 in 9m 2025.

• Upgraded FY 2025 revenue guidance to €435-445 million, with a new FY 2026 target of €570-590 million, reflecting at least 20% organic growth and c.30% total growth including acquisitions.

Financial highlights

• Order intake for the first nine months of 2025 was €232.7 million, up 92.3% year-over-year, and a soft backlog of €591.7 million.

• Adjusted EBITDA rose to €72.3 million from €53.9 million, with a margin of 26% versus 24% last year.

• Capex for the period was €12.5 million, up 8.8% year-over-year, aligned with full-year guidance.

• Net working capital rose to €177.6 million, mainly due to higher inventory in preparation for a strong Q4.

• Net cash position decreased to €0.5 million from €38.1 million in June 2025, reflecting recent investments.

Outlook and guidance

• FY 2025 revenue guidance raised to €435-445 million; FY 2026 revenue target set at €570-590 million.

• Organic growth targeted at >15% for FY 2026, with total growth of c.30% including acquisitions.

• Capex guidance: €20 million for FY 2025, €30 million for FY 2026.

• Dividend payout targeted at 35% of net income for FY 2025, 20-30% for FY 2026.

• Strategic investments and partnerships are expected to support long-term growth and expansion into adjacent markets.